PGR and breast cancer: The objective of this retrospective analysis was to evaluate the prognostic significance of uPA and PAI-1 breast cancer levels in estrogen receptor (ER)-positive and/or progesterone receptor (PR)-positive and HER2-negative node-negative early breast cancer patients who were treated with adjuvant endocrine therapy.